These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24594431)

  • 1. Oral hormonal contraception and venous thromboembolism (VTE).
    Reid RL
    Contraception; 2014 Apr; 89(4):235-6. PubMed ID: 24594431
    [No Abstract]   [Full Text] [Related]  

  • 2. The INAS-OC study.
    Lidegaard O
    Contraception; 2014 Dec; 90(6):617-8. PubMed ID: 25261151
    [No Abstract]   [Full Text] [Related]  

  • 3. Drospirenone and VTE.
    Leppée M; Eric M; Culig J
    J Fam Plann Reprod Health Care; 2010 Jan; 36(1):44. PubMed ID: 20067674
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to letter to the editor: "The INAS-OC study".
    Dinger J
    Contraception; 2014 Dec; 90(6):618-21. PubMed ID: 25263612
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk of venous thromboembolism in women taking the combined oral contraceptive: A systematic review and meta-analysis.
    Bateson D; Butcher BE; Donovan C; Farrell L; Kovacs G; Mezzini T; Raynes-Greenow C; Pecoraro G; Read C; Baber R
    Aust Fam Physician; 2016; 45(1):59-64. PubMed ID: 27051991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drospirenone Litigation: Does the Punishment Fit the Crime?
    Batur P; Casey PM
    J Womens Health (Larchmt); 2017 Feb; 26(2):99-102. PubMed ID: 27854556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives.
    Dinger J; Bardenheuer K; Heinemann K
    Contraception; 2014 Apr; 89(4):253-63. PubMed ID: 24576793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative risks of venous thromboembolism among users of oral contraceptives containing drospirenone and levonorgestrel.
    Heinemann K; Heinemann LA
    J Fam Plann Reprod Health Care; 2011 Jul; 37(3):132-5. PubMed ID: 21659330
    [No Abstract]   [Full Text] [Related]  

  • 9. Thromboembolism associated with the new contraceptive Yasmin.
    van Grootheest K; Vrieling T
    BMJ; 2003 Feb; 326(7383):257. PubMed ID: 12560278
    [No Abstract]   [Full Text] [Related]  

  • 10. The risk of deep venous thrombosis with oral contraceptives containing drospirenone.
    Dunn N
    BMJ; 2011 Apr; 342():d2519. PubMed ID: 21511807
    [No Abstract]   [Full Text] [Related]  

  • 11. Do drospirenone-containing oral contraceptives have a higher risk of VTE?
    Ribowsky JH
    JAAPA; 2011 Aug; 24(8):51-3. PubMed ID: 21850920
    [No Abstract]   [Full Text] [Related]  

  • 12. Venous thromboembolism is egregiously underestimated.
    Shapiro S
    BMJ; 2011 May; 342():d3344. PubMed ID: 21628367
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
    Dinger J; Assmann A; Möhner S; Minh TD
    J Fam Plann Reprod Health Care; 2010 Jul; 36(3):123-9. PubMed ID: 20659364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to the letter from Dr. Szarewski.
    Sidney S
    Contraception; 2013 Apr; 87(4):506-7. PubMed ID: 23246306
    [No Abstract]   [Full Text] [Related]  

  • 15. ACOG Committee Opinion Number 540: Risk of venous thromboembolism among users of drospirenone-containing oral contraceptive pills.
    Committee on Gynecologic Practice
    Obstet Gynecol; 2012 Nov; 120(5):1239-42. PubMed ID: 23090561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study subject to unmeasured confounders and biases.
    Szarewski A; Mansour D
    BMJ; 2011 May; 342():d3349. PubMed ID: 21628369
    [No Abstract]   [Full Text] [Related]  

  • 17. Another flawed database study.
    Szarewski A; Mansour D; Shapiro S
    Contraception; 2013 Apr; 87(4):505-6. PubMed ID: 23261232
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.
    Sehovic N; Smith KP
    Ann Pharmacother; 2010 May; 44(5):898-903. PubMed ID: 20371756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined hormonal contraceptives and venous thromboembolism: putting the risks into perspective.
    Raymond EG; Burke AE; Espey E
    Obstet Gynecol; 2012 May; 119(5):1039-44. PubMed ID: 22525916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined oral contraceptives, venous thromboembolism, and the problem of interpreting large but incomplete datasets.
    Dinger J; Shapiro S
    J Fam Plann Reprod Health Care; 2012 Jan; 38(1):2-6. PubMed ID: 22128104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.